Work

Adjusted indirect comparison using propensity score matching of osimertinib to doublet chemotherapy in patients with EGFRm T790M NSCLC who have progressed after EGFR-TKI

Year: 2016

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdw383.46

Authors: F. Andersohn, H. Mann, T. Mitsudomi, T.S.K. Mok, J. Chih-Hsin Yang, K. Papadakis, C. Hoyle

Institutions: Charité – Universitätsmedizin Berlin, AstraZeneca (United Kingdom), Kindai University, Chinese University of Hong Kong, Prince of Wales Hospital, National Taiwan University Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2587713978

FWCI: 0.299

Cites:

Cited by: 1

Related to: 10